The brand new St. Joseph Companion Aspirin contains a recommended crisis dose and chewable type within an easy-to-open, portable pouch. Related StoriesSexual activity rarely causes center attackHeart attack patients diagnosed and treated for diabetes experience improved cardiac outcomesMajor UK trial to examine role of aspirin in malignancy recurrence It has been approximated that 5,000 to 10,000 lives could be saved every year if people would take aspirin when they experience the symptoms of a heart attack, notes Dr. Jullette Saussy, board-certified emergency medication physician and director for Emergency Medical Services for the town of New Orleans. The St. Joseph Companion Aspirin gives customers a recommended right dose and chewable form.The principal efficacy endpoint for U.S.0 g/dL increase in hemoglobin at any time from baseline to week 5; the principal efficacy endpoint for European Union regulators is the mean transformation in hemoglobin from baseline to week 5. In the IDA-301 trial, ferumoxytol achieved both primary efficacy endpoints.0 g/dL in hemoglobin compared to only 5.5 percent of subjects who received placebo, meeting the protocol defined measure of superiority . The mean modification in hemoglobin in ferumoxytol-treated subjects was 2.7 g/dL, compared to a mean 0.1 g/dL increase in subjects receiving placebo . Data from IDA-301 also demonstrated a primary correlation between a growth in hemoglobin and improvement in subject-reported fatigue ratings using the Functional Assessment of Chronic Disease Therapy instrument.